Active experimental inhibition of cancer by corynebacterium parvum.
It has been demonstrated that 5 microgram Corynebacterium parvum (Mérieux, Lyon) applied i.v. once weekly in mice of the strain C 3 H X Swiss Albino F 1 after three pregnancies effectively inhibits tumour growth. At this time those mice are 100% at risk. The appearance of tumours in the treated group is significantly delayed.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D005260:Female; D007167:Immunotherapy / Q000379:methods; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D011247:Pregnancy; D011425:Propionibacterium acnes / Q000276:immunology*; D013997:Time Factors
D000912:Antibodies, Neoplasm